Semaglutide denied for failing step therapy by Cigna?
Step-therapy denials usually flip when the appeal documents that prior alternatives were tried and failed, or were contraindicated, or aren't safe for the patient.
US health-plan appeal rights
Cite: Most US health plans have appeal rights under either the ACA, ERISA, or Medicare/Medicaid rules
Most US health plans are required by federal law to give you both an internal appeal (where the insurer reconsiders) and an external review (where an independent reviewer decides). The exact timelines and processes depend on what kind of plan you have — marketplace / employer group, self-funded, Medicare Advantage, or Medicaid MCO — but in every case there's a window after the denial during which you have the right to fight it.
What Cigna typically requires
Cigna's specific coverage criteria for semaglutide are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.
The Cigna angle on Semaglutide
## Why Cigna May Deny Semaglutide Under Step Therapy
A step-therapy denial — also called "fail-first" — means Cigna's policy requires you to try and document failure with one or more other medications before it will approve semaglutide. For semaglutide, this typically means demonstrating a prior adequate trial with other agents used for the same indication. The denial does not mean semaglutide is wrong for you; it means the insurer has not yet received evidence that you have completed the required prior steps.
Step-therapy protocols exist in every major commercial formulary and are one of the most common barriers to access for newer branded medications.
## Why This Denial Is Appealable
Step-therapy denials can be overturned in several situations: (1) you already tried the required prior agents and that history was not included in the original authorization; (2) a required prior agent is contraindicated for you as documented in your chart; (3) you tried a prior agent and experienced a medically significant adverse reaction; or (4) a step-therapy exception applies under applicable state law — many states have enacted step-therapy reform laws that require exceptions for patients with documented clinical reasons.
## Your Federal and State Appeal Rights
- Internal appeal: Under ERISA §503 (employer-sponsored plans) or applicable state law (individual and fully-insured plans), you are entitled to a full-and-fair internal review. File within the deadline stated on your denial notice.
- State step-therapy exception laws: If your plan is subject to state regulation (not a self-funded ERISA plan), check whether your state has a step-therapy exception law. These laws often require insurers to grant exceptions without completing all steps when a prior agent is clinically inappropriate.
- External review: Under ACA §2719, if the internal appeal is denied, an independent review organization (IRO) reviews the denial. The external-review window is generally approximately four months from the final internal denial; verify the exact date on your denial letter.
- Expedited review: Request expedited processing if delay would seriously jeopardize your health.
## Documentation to Gather
1. Prior treatment history: This is the most critical document. Provide a chronological list of every medication previously tried for this condition — generic drug name, prescriber, start date, stop date, outcome (ineffective, adverse reaction, contraindicated), and the chart note or pharmacy record supporting each entry. 2. Adverse reaction or contraindication records: If a required step-therapy agent caused a significant adverse event or is contraindicated, provide the chart documentation and your prescriber's signed statement. 3. Adequate trial evidence: Cigna's policy will specify what constitutes an adequate trial (typically a minimum duration of use). Ensure your records document that the trial met that threshold. 4. Prescriber medical-necessity letter: A signed letter addressing Cigna's specific step-therapy criteria, explaining why semaglutide is necessary and why prior steps have been completed or are not appropriate. 5. FDA prescribing label: The approved prescribing information for semaglutide, to document the clinical basis for the prescription.
## Criteria-Mapping Structure
Retrieve Cigna's step-therapy protocol for semaglutide from their published medical or pharmacy policy. Address each step:
| Step-Therapy Requirement (from Cigna policy) | Your Documentation | |----------------------------------------------|--------------------| | Step 1 agent tried and failed | [Generic drug name, dates, outcome, chart reference] | | Step 2 agent tried and failed (if required) | [Generic drug name, dates, outcome, chart reference] | | Exception: agent is contraindicated | [Chart documentation, prescriber attestation] | | Exception: adverse reaction documented | [Reaction description, date, prescriber note] |
A well-documented prior treatment history that addresses every step in Cigna's protocol — or every applicable exception — gives the appeal reviewer a clear, factual basis to approve semaglutide.
Next steps
- Find the date on the denial letter — your appeal window starts there.
- Read your plan's Summary of Benefits and Coverage (SBC) for the specific deadlines.
- Request the insurer's claim file in writing — they must provide it.
- Submit your appeal in writing with new clinical evidence and a physician statement.
Get the letter drafted
DenialHelp drafts your appeal in 5 minutes — $40 list price, $30 for your first letter (use code SEO25). We cite the federal regs and the specific clinical evidence your plan responds to. Your physician signs and sends.
Start my appeal — $30 with code SEO25 →